About Galvanize
Pioneering a new role for pulsed electric field energy in medicine
We believe the future of medical devices lies in unlocking the body’s natural potential.
Galvanize Therapeutics® pioneers pulsed electric field (PEF) technology for oncology and chronic disease. By combining engineering, clinical science, and a deep understanding of energy delivery, we’re developing technologies designed to create new possibilities for patients and physicians.
Our Beginning
Galvanize was formed in 2022 through the merger of Gala Therapeutics and Galaxy Medical, bringing together pioneers in pulsed electric field technology with a shared vision for the future of medicine.
Our founders believed there was an opportunity to rethink how energy could be used in medicine—not simply to destroy tissue, but to engage fundamental biologic processes in ways that could transform patient care.
That belief continues to guide every technology we develop.
Focused where the need is greatest
We focus on diseases where today’s treatment options leave patients with limited choices and poor outcomes.
Our goal isn’t simply to improve existing technologies – it’s to develop new approaches that expand what’s possible for patients.
Board of Directors
Doug Godshall
Chairman and CEO
Galvanize Therapeutics®, Inc.
Seth Harrison, MD
Founder and Managing Partner,
ATP (Apple Tree Partners)
Antoine Papiernik
Chairman & Managing Partner,
Sofinnova Partners
Zack Scott, MD
General Partner,
Norwest Venture Partners
David Lewis
Managing Partner,
Gilmartin Capital
Laura Francis
CEO and Board Member,
SI-BONE, Inc.
Careers
Build what’s next
We’re a focused team taking on hard problems in oncology and chronic disease. If you want your work to make a lasting impact on patients around the world, we’d like to meet you.
Request Information
"*" indicates required fields